Skip to content

Yew Bio-Pharm Group, Inc.: 10-Q filed 2014-11-17

What Yew Bio-Pharm Group, Inc. reported in its quarterly report filed 2014-11-17 (fiscal Q3 2014): 39 published measures, 107 facts as tagged in accession 0001213900-14-008299.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-17
Fiscal period
fiscal Q3 2014
Accession
0001213900-14-008299 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Yew Bio-Pharm Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-3034,557,140USD
At 2013-12-3135,313,908USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-30440,269USD
At 2013-12-314,997,582USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-3034,116,871USD
At 2013-12-3130,316,326USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-30120,118USD
At 2013-12-311,159,611USD
At 2013-09-301,110,025USD
At 2012-12-31386,821USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30892,716USD92
2014-01-01 to 2014-09-303,685,428USD273
2013-07-01 to 2013-09-30592,212USD92
2013-01-01 to 2013-09-302,857,232USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-09-303,495,168USD273
2013-01-01 to 2013-09-301,435,536USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-09-303,390USD273
2013-01-01 to 2013-09-30217,604USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-07-01 to 2014-09-301,700,924USD92
2014-01-01 to 2014-09-305,832,468USD273
2013-07-01 to 2013-09-301,544,327USD92
2013-01-01 to 2013-09-305,449,633USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-25,064USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-4,501,474USD273
2013-01-01 to 2013-09-30-731,289USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-3019,929,747USD
At 2013-12-3116,664,138USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-07-01 to 2014-09-3051,639,946shares92
2014-01-01 to 2014-09-3050,552,656shares273
2013-07-01 to 2013-09-3050,000,000shares92
2013-01-01 to 2013-09-3050,000,000shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-07-01 to 2014-09-3051,759,743shares92
2014-01-01 to 2014-09-3063,026,963shares273
2013-07-01 to 2013-09-3050,000,000shares92
2013-01-01 to 2013-09-3050,000,000shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.02USD/shares92
2014-01-01 to 2014-09-300.07USD/shares273
2013-07-01 to 2013-09-300.01USD/shares92
2013-01-01 to 2013-09-300.06USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.02USD/shares92
2014-01-01 to 2014-09-300.06USD/shares273
2013-07-01 to 2013-09-300.01USD/shares92
2013-01-01 to 2013-09-300.06USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-30894,108USD
At 2013-12-311,033,078USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-07-01 to 2014-09-305,657USD92
2014-01-01 to 2014-09-305,657USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-09-30893,588USD92
2014-01-01 to 2014-09-303,684,045USD273
2013-07-01 to 2013-09-30590,132USD92
2013-01-01 to 2013-09-302,855,685USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-303,506,186USD
At 2013-12-313,082,122USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-30440,269USD
At 2013-12-314,997,582USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-3015,959USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-09-3019,598,367USD
At 2013-12-3120,953,562USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-31377,821USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-30513,539USD92
2014-01-01 to 2014-09-30901,957USD273
2013-07-01 to 2013-09-30315,967USD92
2013-01-01 to 2013-09-30871,529USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-09-301,731,628USD
At 2013-12-311,089,087USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-301,407,127USD92
2014-01-01 to 2014-09-304,586,002USD273
2013-07-01 to 2013-09-30906,099USD92
2013-01-01 to 2013-09-303,727,214USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-07-01 to 2014-09-30293,797USD92
2014-01-01 to 2014-09-301,246,466USD273
2013-07-01 to 2013-09-30638,228USD92
2013-01-01 to 2013-09-301,722,419USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-3052,125,000shares
At 2013-12-3150,000,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-09-308,383,084USD
At 2013-12-318,058,165USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-09-3037,180USD
At 2013-12-312,697USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-30892,716USD92
2014-01-01 to 2014-09-303,685,428USD273
2013-07-01 to 2013-09-30592,212USD92
2013-01-01 to 2013-09-302,857,232USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-07-01 to 2014-09-30903,276USD92
2014-01-01 to 2014-09-303,473,502USD273
2013-07-01 to 2013-09-30772,556USD92
2013-01-01 to 2013-09-303,635,099USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30506,566USD92
2014-01-01 to 2014-09-30892,563USD273
2013-07-01 to 2013-09-30308,611USD92
2013-01-01 to 2013-09-30852,480USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-09-30132,355USD273
2013-01-01 to 2013-09-30147,782USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-617USD92
2014-01-01 to 2014-09-301,347USD273
2013-07-01 to 2013-09-301,919USD92
2013-01-01 to 2013-09-301,302USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-872USD92
2014-01-01 to 2014-09-301,383USD273
2013-07-01 to 2013-09-302,080USD92
2013-01-01 to 2013-09-301,547USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-301,189,571USD273
2013-01-01 to 2013-09-30282,524USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30205,265USD273
2013-01-01 to 2013-09-30594,434USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-3015,974USD273
2013-01-01 to 2013-09-303,357USD273

Inspect the source

Entity
Yew Bio-Pharm Group, Inc. / CIK 0001548240
Captured
SEC response SHA-256
42d239bf62595328b4b0f26c5a40397396731e01ab6dfcaf5b29c1b41870e6be

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001548240.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))